Jennison Associates’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $100M | Sell |
2,467,998
-24,642
| -1% | -$998K | 0.06% | 133 |
|
|
2025
Q1 | $128M | Sell |
2,492,640
-7,492
| -0.3% | -$385K | 0.09% | 112 |
|
|
2024
Q4 | $138M | Buy |
2,500,132
+321,552
| +15% | +$17.8M | 0.08% | 107 |
|
|
2024
Q3 | $71.7M | Buy |
2,178,580
+698,712
| +47% | +$23M | 0.04% | 168 |
|
|
2024
Q2 | $40.2M | Buy |
1,479,868
+148,930
| +11% | +$4.05M | 0.03% | 247 |
|
|
2024
Q1 | $48.4M | Buy |
+1,330,938
| New | +$48.4M | 0.03% | 222 |
|